Skip to main content
ConductScienceScienceDex

Lieberman, Paul M.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #879
Unclaimed recordClaim profile
  • Sustained Excellence
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$4.5M
Full award amounts, FY2023
Award Records
6
Records listing this PI
Award-Linked Rank
#879
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lieberman, Paul M.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Lieberman, Paul M. as a PI. Multi-PI records show the full award amount for context.

  • 1P01CA269043-01A1P01Contact PI
    Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
    Wistar Institute
    $2.4M
    award amount
  • 1R01CA282411-01R01Contact PI
    EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
    Wistar Institute
    $745.8K
    award amount
  • 5R01CA140652-13R01Contact PI
    Role of TERRA in Telomere Maintenance and Telomere Stress Response
    Wistar Institute
    $434.7K
    award amount
  • 2R01CA117830-16A1R01Contact PI
    Epigenomic Control of KSHV Latency
    Wistar Institute
    $410.2K
    award amount
  • 5R01DE017336-15R01Contact PI
    Epigenetic Regulation of Epstein-Barr Virus
    Wistar Institute
    $364.6K
    award amount
  • 3R01CA259171-03S1R01Contact PI
    Drugging EBNA1 to Treat EBV-Associated Cancers - Diversity Supplement
    Wistar Institute
    $135.8K
    award amount

Award organization

Organizations that administered FY2023 awards listing Lieberman, Paul M. as a PI.

FY2023 award administered by Wistar Institute (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Wistar Institute
  2. 2006
    $500K Cumulative Funding
  3. 2006
    $1M Cumulative Funding
  4. 2006
    Entered Top 50% Nationally
    Ranked #4652
  5. 2006
    Entered Top 25% Nationally
    Ranked #4652
  6. 2008
    $2M Cumulative Funding
  7. 2010
    $5M Cumulative Funding
  8. 2012
    R01 Grant Holder
  9. 2013
    $10M Cumulative Funding
  10. 2015
    Program/Center Grant Leader
  11. 2021
    $25M Cumulative Funding
  12. 2023
    Entered Top 10% Nationally
    Ranked #879
  13. 2023
    Entered Top 5% Nationally
    Ranked #879

Explore further

Find collaborators for Lieberman, Paul M.

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →